‹
›
This content requires a premium subscription.
Please
log in
or
subscribe
to continue.
ACCEL Lite: Featured ACCEL Interviews on Exciting CV Research
ACCEL Lite: ACC.22 Late Breaker: ADAPT-TAVR Trial - Edoxaban Versus DAPT For Valve Thrombosis And Cerebral TE After TAVR
30
00:00:00
/ 00:11:49
30